BioCentury
ARTICLE | Clinical News

LIM-0705: Phase Ia data

March 15, 2010 7:00 AM UTC

In the multiple-ascending dose portion of a Phase Ia trial in 28 healthy volunteers, LIM-0705 significantly reduced the tissue distribution of tacrolimus compared to tacrolimus alone (p<0.001). There ...